Ozempic Pharmaceuticals Processes Use of Brazilian Pen; Understand
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The manufacturer Novo Nordisk has filed a lawsuit in Federal Court to try to annul the registration of the Ozivy brand, which belongs to the Brazilian pharmaceutical company EMS. The lawsuit was filed in the 31st Federal Court of Rio de Janeiro this Wednesday (June 17, 2026). According to the Danish company, the name of its rival's new drug causes confusion and undue association with its own products – Ozempic and Wegovy. According to Novo Nordi…
The Danish pharmacist Novo Nordisk entered the court to try to prevent the use of the brand name Ozivy, an EMS medicine launched this week in Brazil for the treatment of type 2 diabetes.The company requests the annulment of the registration granted by the National Institute of Industrial Property (INPI), claiming that the name chosen by the Brazilian pharmacist violates the brands Ozempic and Wegovy.The action was registered at the 31st Federal …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
